Factor V inhibitor associated with Sjögren's syndrome

Takatoshi Koyama, Takako Saito, Takayoshi Kusano, SHINSAKU Hirosawa

Research output: Contribution to journalArticlepeer-review

35 Citations (Scopus)


We report an unusual case of a 74‐year‐old male who developed a serum autoantibody reactive with human coagulation factor V (FV) in an activated form, as demonstrated by coagulation studies and immunoblotting analysis. Despite marked prolongation of a prothrombin time and an activated partial thromboplastin time in this patient, the inhibitor was not associated with clinical bleeding but with multiple cerebral infarctions. The patient had suffered from Sjögren's syndrome with polyclonal hypergamma‐globulinaemia. The patient's purified IgG, an immediately acting inhibitor to FV, reacted with a light chain of thrombin‐activated FV (FVa) and inhibited the procoagulant activity of FVa without affecting the cleavage of FVa by activated protein C. The FV inhibitor may arise from activation of FV with consequent exposure of neoantigen during the activation of coagulation cascade in the patient with an autoimmune disorder for the background.

Original languageEnglish
Pages (from-to)893-896
Number of pages4
JournalBritish Journal of Haematology
Issue number4
Publication statusPublished - 1995 Apr


  • Sjögren's syndrome
  • activated factor V light chain
  • activated protein C
  • factor V inhibitor
  • hypergammaglobulinaemia


Dive into the research topics of 'Factor V inhibitor associated with Sjögren's syndrome'. Together they form a unique fingerprint.

Cite this